Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 stu... by Swain, Sandra M, Prof, Miles, David, Prof, Kim, Sung-Bae, Prof, Im, Young-Hyuck, Prof, Im, Seock-Ah, Prof, Semiglazov, Vladimir, Prof, Ciruelos, Eva, MD, Schneeweiss, Andreas, Prof, Loi, Sherene, Prof, Monturus, Estefanía, PhD, Clark, Emma, MSc, Knott, Adam, PhD, Restuccia, Eleonora, MD, Benyunes, Mark C, MD, Cortés, Javier, Prof

Get full text